DIVI S LABORATORIES LTD vs GUFIC BIOSCIENCES LTD.

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and GUFIC BIOSCIENCES LTD. (GUFICBIO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs GUFICBIO on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

Valuation

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

74.93
P/E ratio
54.79
10.72
P/B ratio
5.84
0.44%
Dividend yield
0.03%
₹96.73
EPS
₹6.97

Profitability

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
11.59%
22.00%
Return on capital
13.00%
33.00%
EBITDA margin
17.00%
24.32%
Net margin
8.54%

Growth

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
10.96%
12.10%
Profit CAGR (3Y)
-7.07%

Size & financial health

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.92L Cr
Market cap
₹3,835 Cr
₹10,560 Cr
Revenue
₹820 Cr
₹2,568 Cr
Net profit
₹70 Cr
0.00
Debt / equity
0.61
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 10.8 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
GUFIC BIOSCIENCES LTD.
  • ["Stock is trading at 5.92 times its book value", "Company has a low return on equity of 13.5% over last 3 years.", "Dividend payout has been low at 1.40% of profits over last 3 years"]
DIVI S LABORATORIES LTD full analysis GUFIC BIOSCIENCES LTD. full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.